[1] W.S. Foster, C.M. Suen, D.J. Stewart, Regenerative cell and tissue-based therapies for pulmonary arterial hypertension, Can J Cardiol, 30 (2014) 1350-1360.
[2] Q. Zhou, C. Yang, P. Yang, The Promotional Effect of Mesenchymal Stem Cell Homing on Bone Tissue Regeneration, Curr Stem Cell Res Ther, 12 (2017) 365-376.
[3] T. Hansen, K.K. Galougahi, D. Celermajer, N. Rasko, O. Tang, K.J. Bubb, G. Figtree, Oxidative and nitrosative signalling in pulmonary arterial hypertension - Implications for development of novel therapies, Pharmacol Ther, 165 (2016) 50-62.
[4] R.A. Denu, P. Hematti, Effects of Oxidative Stress on Mesenchymal Stem Cell Biology, Oxid Med Cell Longev, 2016 (2016) 2989076.
[5] S. Pervaiz, R. Taneja, S. Ghaffari, Oxidative stress regulation of stem and progenitor cells, Antioxid Redox Signal, 11 (2009) 2777-2789.
[6] M. Rodrigues, O. Turner, D. Stolz, L.G. Griffith, A. Wells, Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligand, Cell Transplant, 21 (2012) 2171-2187.
[7] L. Li, X. Chen, W.E. Wang, C. Zeng, How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?, Stem Cells Int, 2016 (2016) 9682757.
[8] B. Subramani, S. Subbannagounder, C. Ramanathanpullai, S. Palanivel, R. Ramasamy, Impaired redox environment modulates cardiogenic and ion-channel gene expression in cardiac-resident and non-resident mesenchymal stem cells, Exp Biol Med (Maywood), 242 (2017) 645-656.
[9] J. Avruch, D. Zhou, J. Fitamant, N. Bardeesy, F. Mou, L.R. Barrufet, Protein kinases of the Hippo pathway: regulation and substrates, Semin Cell Dev Biol, 23 (2012) 770-784.
[10] M. Odashima, S. Usui, H. Takagi, C. Hong, J. Liu, M. Yokota, J. Sadoshima, Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction, Circ Res, 100 (2007) 1344-1352.
[11] W. Yu, M. Xu, T. Zhang, Q. Zhang, C. Zou, Mst1 promotes cardiac ischemia-reperfusion injury by inhibiting the ERK-CREB pathway and repressing FUNDC1-mediated mitophagy, The journal of physiological sciences : JPS, 69 (2019) 113-127.
[12] M. Zhang, L. Zhang, J. Hu, J. Lin, T. Wang, Y. Duan, W. Man, J. Feng, L. Sun, H. Jia, C. Li, R. Zhang, H. Wang, D. Sun, MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice, Diabetologia, 59 (2016) 2435-2447.
[13] K. Vijayakumar, G.W. Cho, Autophagy: An evolutionarily conserved process in the maintenance of stem cells and aging, Cell Biochem Funct, 37 (2019) 452-458.
[14] P. Boya, R.A. Gonzalez-Polo, N. Casares, J.L. Perfettini, P. Dessen, N. Larochette, D. Metivier, D. Meley, S. Souquere, T. Yoshimori, G. Pierron, P. Codogno, G. Kroemer, Inhibition of macroautophagy triggers apoptosis, Mol Cell Biol, 25 (2005) 1025-1040.
[15] K.Y. DeLeon-Pennell, A.J. Mouton, O.K. Ero, Y. Ma, R. Padmanabhan Iyer, E.R. Flynn, I. Espinoza, S.K. Musani, R.S. Vasan, M.E. Hall, E.R. Fox, M.L. Lindsey, LXR/RXR signaling and neutrophil phenotype following myocardial infarction classify sex differences in remodeling, Basic Res Cardiol, 113 (2018) 40.
[16] T. Suzuki, M. Yamamoto, Molecular basis of the Keap1-Nrf2 system, Free Radic Biol Med, 88 (2015) 93-100.
[17] M. Yamamoto, T.W. Kensler, H. Motohashi, The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis, Physiol Rev, 98 (2018) 1169-1203.
[18] N. Rajabzadeh, E. Fathi, R. Farahzadi, Stem cell-based regenerative medicine, Stem Cell Investig, 6 (2019) 19.
[19] C.M. Ryan, J.A. Brown, E. Bourke, A.M. Prendergast, C. Kavanagh, Z. Liu, P. Owens, G. Shaw, W. Kolch, T. O'Brien, F.P. Barry, ROCK activity and the Gbetagamma complex mediate chemotactic migration of mouse bone marrow-derived stromal cells, Stem Cell Res Ther, 6 (2015) 136.
[20] E. Fathi, R. Farahzadi, N. Sheikhzadeh, Immunophenotypic characterization, multi-lineage differentiation and aging of zebrafish heart and liver tissue-derived mesenchymal stem cells as a novel approach in stem cell-based therapy, Tissue Cell, 57 (2019) 15-21.
[21] W. Yu, H. Chen, H. Yang, J. Ding, P. Xia, X. Mei, L. Wang, S. Chen, C. Zou, L.X. Wang, Dissecting Molecular Mechanisms Underlying Pulmonary Vascular Smooth Muscle Cell Dedifferentiation in Pulmonary Hypertension: Role of Mutated Caveolin-1 (Cav1(F92A))-Bone Marrow Mesenchymal Stem Cells, Heart Lung Circ, 28 (2019) 1587-1597.
[22] E. Fathi, R. Farahzadi, B. Valipour, Z. Sanaat, Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation, PLoS One, 14 (2019) e0215678.
[23] J.M. Karp, G.S. Leng Teo, Mesenchymal stem cell homing: the devil is in the details, Cell Stem Cell, 4 (2009) 206-216.
[24] A.J. Kowaltowski, N.C. de Souza-Pinto, R.F. Castilho, A.E. Vercesi, Mitochondria and reactive oxygen species, Free Radic Biol Med, 47 (2009) 333-343.
[25] S.W. Tait, D.R. Green, Mitochondria and cell death: outer membrane permeabilization and beyond, Nat Rev Mol Cell Biol, 11 (2010) 621-632.
[26] V.R. Burst, M. Gillis, F. Putsch, R. Herzog, J.H. Fischer, P. Heid, J. Muller-Ehmsen, K. Schenk, J.W. Fries, C.A. Baldamus, T. Benzing, Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury, Nephron Exp Nephrol, 114 (2010) e107-116.
[27] H. Naderi-Meshkin, A.R. Bahrami, H.R. Bidkhori, M. Mirahmadi, N. Ahmadiankia, Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy, Cell Biol Int, 39 (2015) 23-34.
[28] E. Itakura, C. Kishi, K. Inoue, N. Mizushima, Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG, Mol Biol Cell, 19 (2008) 5360-5372.
[29] Y. Maejima, S. Kyoi, P. Zhai, T. Liu, H. Li, A. Ivessa, S. Sciarretta, D.P. Del Re, D.K. Zablocki, C.P. Hsu, D.S. Lim, M. Isobe, J. Sadoshima, Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2, Nat Med, 19 (2013) 1478-1488.
[30] S.R. Yang, J.R. Park, K.S. Kang, Reactive Oxygen Species in Mesenchymal Stem Cell Aging: Implication to Lung Diseases, Oxid Med Cell Longev, 2015 (2015) 486263.
[31] C. Hu, L. Zhao, C. Peng, L. Li, Regulation of the mitochondrial reactive oxygen species: Strategies to control mesenchymal stem cell fates ex vivo and in vivo, J Cell Mol Med, 22 (2018) 5196-5207.
[32] Q. Tian, S. Wu, Z. Dai, J. Yang, J. Zheng, Q. Zheng, Y. Liu, Iron overload induced death of osteoblasts in vitro: involvement of the mitochondrial apoptotic pathway, PeerJ, 4 (2016) e2611.
[33] L. Wang, X. Guo, X. Guo, X. Zhang, J. Ren, Decitabine promotes apoptosis in mesenchymal stromal cells isolated from patients with myelodysplastic syndromes by inducing reactive oxygen species generation, Eur J Pharmacol, 863 (2019) 172676.
[34] M.A. Lampert, A.B. Gustafsson, Mitochondria and autophagy in adult stem cells: proliferate or differentiate, J Muscle Res Cell Motil, (2019).
[35] T.T. Ho, M.R. Warr, E.R. Adelman, O.M. Lansinger, J. Flach, E.V. Verovskaya, M.E. Figueroa, E. Passegue, Autophagy maintains the metabolism and function of young and old stem cells, Nature, 543 (2017) 205-210.
[36] Y. Maejima, [The critical role of autophagy in heart failure], Nihon Yakurigaku Zasshi, 151 (2018) 100-105.
[37] P. Wang, J. Geng, J. Gao, H. Zhao, J. Li, Y. Shi, B. Yang, C. Xiao, Y. Linghu, X. Sun, X. Chen, L. Hong, F. Qin, X. Li, J.S. Yu, H. You, Z. Yuan, D. Zhou, R.L. Johnson, L. Chen, Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis, Nat Commun, 10 (2019) 755.
[38] K. Taguchi, N. Fujikawa, M. Komatsu, T. Ishii, M. Unno, T. Akaike, H. Motohashi, M. Yamamoto, Keap1 degradation by autophagy for the maintenance of redox homeostasis, Proc Natl Acad Sci U S A, 109 (2012) 13561-13566.